This approach has been used to redirect adenoviral tropism and a mutated form of the IL13 ligand has been used to direct CAR T-cells (e.g. IL13-zetakine T cells)10, 11 or adenovirus18 to this tumor specific receptor. Here, IL13 is linked to neoplasm.